Measurement of Fibrinogen in Patients With Systemic Inflammatory Response Syndrome (SIRS), Sepsis or Chronicle Liver Disease on Intensive Care Units (ICU)
1 other identifier
observational
250
1 country
1
Brief Summary
In this study patients with
- primary biliary cirrhosis
- primary sclerosing cholangitis
- alcoholic liver cirrhosis
- hepatitis b or C
- Wilson's disease
- cryptogenic cirrhosis
- Septic Inflammatory Response Syndrome (SIRS)
- sepsis
- septic shock
- patients after lysis
- Clauss fibrinogen
- PT-Derived fibrinogen
- immunoturbidimetric method
- heat-precipitated fibrinogen
- Schulz fibrinogen The result of these tests will be correlated with laboratory values which are gathered in routine and the clinical outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2010
CompletedFirst Submitted
Initial submission to the registry
July 23, 2010
CompletedFirst Posted
Study publicly available on registry
July 26, 2010
CompletedJuly 26, 2010
July 1, 2010
July 23, 2010
July 23, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Fibrinogen levels from 5 test methods
* Clauss fibrinogen * PT-Derived fibrinogen * immunoturbidimetric method * heat-precipitated fibrinogen * Schulz fibrinogen
Secondary Outcomes (5)
Number of bleedings
Number of administered fresh frozen plasma
Number of administered erythrocyte concentrates
Number of administered thrombocyte concentrates
mortality
Eligibility Criteria
patients in intensive care units of the university hospital
You may qualify if:
- SIRS
- sepsis
- septic shock
- chronicle liver disease (MELD-Score \>10)
- patient after lysis
- patient agrees
You may not qualify if:
- no agreement
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Johann Wolfgang Goethe University Hospital
Frankfurt am Main, Hesse, 60590, Germany
Biospecimen
citrated plasma
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
July 23, 2010
First Posted
July 26, 2010
Study Start
April 1, 2010
Last Updated
July 26, 2010
Record last verified: 2010-07